Taylor Boyd
InvestorChief Business Officer at Avalo Therapeutics
Raleigh, North Carolina, United States
About
Nearly 15 years of biotech business development, corporate finance, and investment banking experience. Recently served as Executive Vice President and Chief Business Officer at Abzena leading M&A and licensing initiatives. Previously VP and Head of Business Development at Longboard Pharmaceuticals (acquired for $2.6 billion by Lundbeck) and held investment banking roles executing over $40 billion in transactions.
Experience
- Avalo TherapeuticsSenior Vice President, Clinical Development Operationscurrent2025 — presentWayne, Pennsylvania, United States
- Marinus PharmaSenior Vice President, Clinical Development Operations2025Radnor, Pennsylvania, United States
- Marinus PharmaVice President, Clinical Development Operations2023 — 2024Radnor, Pennsylvania, United States
- Marinus PharmaExecutive Director, Clinical Development Operations2022 — 2023Radnor, Pennsylvania, United States
- Marinus PharmaSenior Director, R&D Program Management2022Radnor, Pennsylvania, United States
- Marinus PharmaDirector, Program Management R&D2021Radnor, Pennsylvania, United States
- University of the Sciences in PhiladelphiaData Science Advisory Board Membe2020 — 2022Philadelphia, Pennsylvania, United States
- PRA Health SciencesSenior Director of Operations - Real World Solutions2019 — 2021Blue Bell, Pennsylvania, United States
- PRA Health SciencesDirector of Operations - Late Phase Services2009 — 2018Blue Bell, PA
- PRA Health SciencesProject Director (Clinical)2000 — 2009
- Rutgers Pharmaceutical Industry Fellowship (RPIF) ProgramPharmacoeconomics and Outcomes Research Fellow1999 — 2001
Skills & more
Phase IIDrug Development1Clinical Leadership1InfusionsOperationsOncology
From Taylor's professional profile.
Colleagues at Avalo Therapeutics
Aaron Kantoff
Board Member at Avalo Therapeutics
Aaron Kantoff
Managing Partner at Scion Life Sciences
Amy Conrad
Senior Events Manager at Volta Labs
Amy Conrad
Director of Events & Community Engagement at Volta
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Chris Sullivan
Chief Financial Officer at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Dino C. Miano
Senior Vice President, CMC and Technical Operations at Avalo Therapeutics
Frequently asked questions
- Who is Taylor Boyd?
- Nearly 15 years of biotech business development, corporate finance, and investment banking experience. Recently served as Executive Vice President and Chief Business Officer at Abzena leading M&A and licensing initiatives. Previously VP and Head of Business Development at Longboard Pharmaceuticals (acquired for $2.6 billion by Lundbeck) and held investment banking roles executing over $40 billion in transactions.
- Where does Taylor Boyd work?
- Taylor Boyd is Chief Business Officer at Avalo Therapeutics.
- Where did Taylor Boyd go to school?
- Taylor Boyd studied at University of the Sciences in Philadelphia (Doctor of Pharmacy - PharmD, Pharmacy); University of the Sciences in Philadelphia (Bachelor of Science - BS, Pharmacy).
